TCN 213 |
| Catalog No.GC14770 |
TCN 213은 선택적이고 극복 가능한 글리신 의존성 GluN1/GluN2A NMDAR 길항제이며 IC50은 각각 75, 750, 7500nM 글리신이 있을 때 0.55, 3.5, 40μM입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 556803-08-8
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 556803-08-8 | SDF | |
| Chemical Name | 2-((5-(benzylamino)-1,3,4-thiadiazol-2-yl)thio)-N-(cyclohexylmethyl)acetamide | ||
| Canonical SMILES | O=C(CSC1=NN=C(NCC2=CC=CC=C2)S1)NCC3CCCCC3 | ||
| Formula | C18H24N4OS2 | M.Wt | 376.54 |
| Solubility | <28.24mg/ml in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6558 mL | 13.2788 mL | 26.5576 mL |
| 5 mM | 0.5312 mL | 2.6558 mL | 5.3115 mL |
| 10 mM | 0.2656 mL | 1.3279 mL | 2.6558 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC37578 S107 hydrochloride
- GC50003 AG 490
- GC35142 4-O-beta-Glucopyranosyl-cis-coumaric acid
- GC38949 Thalidomide-NH-PEG2-C2-NH2 TFA
- GN10534 Asiaticoside
- GC14516 Mesulergine hydrochloride
- GC61198 Polyporusterone B
- GC36618 Mitiglinide calcium hydrate
- GC34068 McMMAF (Maleimidocaproyl monomethylauristatin F)
- GC34364 OT antagonist 1 demethyl derivative
- GC33477 Folcisteine
- GC36137 Ginsenoside F4
- GC17642 JMV 390-1
- GC13428 Mosapride
- GC17761 STA-21
- GC45150 Voacamine
- GC30994 Vanilpyruvic acid (Vanylpyruvic acid)
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *